Search for: "IN RE WYETH"
Results 401 - 420
of 702
Sort by Relevance
|
Sort by Date
21 Apr 2010, 12:08 pm
Wyeth Inc., 2008 WL 2856146 (N.J. [read post]
18 Apr 2010, 5:11 pm
In re Bayer Corp. [read post]
18 Apr 2010, 8:59 am
. * * * * * For ninety percent of readers, everything you’re going to want to know about this post appears above. [read post]
5 Apr 2010, 4:30 am
This re-affirmed rule will become particularly important as these types of suits increase. [read post]
1 Apr 2010, 1:42 pm
See In re Fosamax Products Liability Litigation, 647 F. [read post]
30 Mar 2010, 9:23 am
The Constitution’s dead, they’re talkin’ about wheat. [read post]
17 Mar 2010, 7:27 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004). [read post]
16 Mar 2010, 5:44 am
Wyeth. [read post]
11 Mar 2010, 12:23 pm
If you’re a defendant, you know you’re in trouble when the court decides it’s on a first-name basis with the plaintiff. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
10 Mar 2010, 5:22 am
(Patent Docs) (GenericsWeb) Protonix (Pantoprazole) - US: District Court dismisses Wyeth Lanham Act case concerning generic Protonix, but leaves the door open for further litigation (FDA Law Blog) ReFacto (Moroctocog alfa)- US: Novartis prevails over Pfizer in ReFacto suit (Patent Docs) Vytorin (Ezetimibe, Simvastatin) – US: Infringement of patent following a Paragraph IV certification: Schering Corp. et al. v. [read post]
10 Mar 2010, 5:00 am
Wyeth. [read post]
9 Mar 2010, 12:57 am
Wyeth, a test of the scope of the pre-emption provision of the National Childhood Vaccine Injury Act of 1986. [read post]
4 Mar 2010, 10:58 am
So, even if you're not promoting an off-label use, Parisian would impose a duty to research them. [read post]
4 Mar 2010, 8:13 am
United States Docket: 09-636 Issue: Whether the “unambiguous and unequivocal request” rule about invocation or waiver of the right to counsel applies in both pre- and post-waiver settings, thereby eliminating the government’s heavy burden of proving that a waiver has occurred or instead applies only in post-waiver or re-invocation settings, after the heavy burden has been met. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to… [read post]
25 Feb 2010, 6:34 am
By Brian WolfmanIn Wyeth v. [read post]
25 Feb 2010, 12:15 am
While clients may appreciate knowing what level of service they're paying for, he added that clients may also shy away from hiring the lowest performers. [read post]
24 Feb 2010, 2:15 pm
We’re pleased – but perplexed. [read post]
